CGEM
Price
$9.49
Change
-$0.12 (-1.25%)
Updated
Sep 22, 6:59 PM EST
50 days until earnings call
GOSS
Price
$0.80
Change
-$0.03 (-3.61%)
Updated
Sep 22, 6:59 PM EST
51 days until earnings call

Compare trend and price CGEM vs GOSS

Header iconCGEM vs GOSS Comparison
Open Charts CGEM vs GOSSBanner chart's image
Cullinan Oncology
Price$9.49
Change-$0.12 (-1.25%)
Volume$77.01K
CapitalizationN/A
Gossamer Bio
Price$0.80
Change-$0.03 (-3.61%)
Volume$1.06M
CapitalizationN/A
View a ticker or compare two or three
CGEM vs GOSS Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CGEM vs. GOSS commentary
Sep 24, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Hold and GOSS is a Hold.

COMPARISON
Comparison
Sep 24, 2023
Stock price -- (CGEM: $9.49 vs. GOSS: $0.80)
Brand notoriety: CGEM and GOSS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 83% vs. GOSS: 74%
Market capitalization -- CGEM: $405.55M vs. GOSS: $180.19M
CGEM [@Biotechnology] is valued at $405.55M. GOSS’s [@Biotechnology] market capitalization is $180.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileGOSS’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • GOSS’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 3 TA indicator(s) are bullish while GOSS’s TA Score has 4 bullish TA indicator(s).

  • CGEM’s TA Score: 3 bullish, 7 bearish.
  • GOSS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GOSS is a better buy in the short-term than CGEM.

Price Growth

CGEM (@Biotechnology) experienced а -4.72% price change this week, while GOSS (@Biotechnology) price change was -13.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.79%. For the same industry, the average monthly price growth was +32.38%, and the average quarterly price growth was +31.88%.

Reported Earning Dates

CGEM is expected to report earnings on Nov 13, 2023.

GOSS is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Biotechnology (-4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CGEM with price predictions.
OPEN
A.I.dvisor published
a Summary for GOSS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CGEM($406M) has a higher market cap than GOSS($180M). CGEM YTD gains are higher at: -10.047 vs. GOSS (-63.147). CGEM has higher annual earnings (EBITDA): -162.51M vs. GOSS (-188.4M). CGEM has more cash in the bank: 492M vs. GOSS (162M). CGEM has less debt than GOSS: CGEM (6.27M) vs GOSS (219M). CGEM (0) and GOSS (0) have equivalent revenues.
CGEMGOSSCGEM / GOSS
Capitalization406M180M226%
EBITDA-162.51M-188.4M86%
Gain YTD-10.047-63.14716%
P/E Ratio8.37N/A-
Revenue00-
Total Cash492M162M304%
Total Debt6.27M219M3%
TECHNICAL ANALYSIS
Technical Analysis
CGEMGOSS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PINRX12.330.01
+0.08%
Principal Diversified Intl R3
LVOYX17.310.01
+0.06%
Lord Abbett Value Opportunities I
GCHDX10.62-0.01
-0.09%
Gotham Hedged Core Institutional
IEGIX18.73-0.03
-0.16%
Invesco EQV Intl Small Company R5
LMRIX25.15-0.14
-0.55%
1919 Financial Services I

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-1.25%
MDGL - CGEM
50%
Loosely correlated
-3.87%
GOSS - CGEM
45%
Loosely correlated
-3.96%
CYTK - CGEM
44%
Loosely correlated
-0.93%
ORMP - CGEM
42%
Loosely correlated
-1.14%
INSM - CGEM
38%
Loosely correlated
-0.65%
More

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with GTHX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then GTHX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-3.96%
GTHX - GOSS
46%
Loosely correlated
-3.15%
CGEM - GOSS
45%
Loosely correlated
-1.25%
MEIP - GOSS
44%
Loosely correlated
+14.05%
TVTX - GOSS
42%
Loosely correlated
+2.75%
APVO - GOSS
41%
Loosely correlated
+2.99%
More